Cargando…
Effect of Hydroxychloroquine on Lupus Activity, Preeclampsia and Intrauterine Growth Restriction in Pregnant Women with Systemic Lupus Erythematosus and/or Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis
Background: Hydroxychloroquine (HCQ) has been used in the treatment of systematic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), but its effect on lupus activity during pregnancy, preeclampsia and intrauterine growth restriction (IUGR) remains unclear. Methods: PubMed, Embase and Coc...
Autores principales: | Hu, Zhengyan, Gao, Rui, Huang, Wanrong, Wang, Huiqing, Qin, Lang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866542/ https://www.ncbi.nlm.nih.gov/pubmed/36675415 http://dx.doi.org/10.3390/jcm12020485 |
Ejemplares similares
-
The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus
por: Bremme, Katarina, et al.
Publicado: (2021) -
Efficacy of Hydroxychloroquine for Improving Pregnancy Outcomes in a Female with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Takaki, Yumika, et al.
Publicado: (2022) -
Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019) -
IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Reshetnyak, Tatiana, et al.
Publicado: (2022) -
The Coexistence of Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Colombians
por: Franco, Juan-Sebastian, et al.
Publicado: (2014)